155 related articles for article (PubMed ID: 22660000)
1. Xerostomia and medication: a cross-sectional study in long-term geriatric wards.
Desoutter A; Soudain-Pineau M; Munsch F; Mauprivez C; Dufour T; Coeuriot JL
J Nutr Health Aging; 2012; 16(6):575-9. PubMed ID: 22660000
[TBL] [Abstract][Full Text] [Related]
2. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups.
Loesche WJ; Bromberg J; Terpenning MS; Bretz WA; Dominguez BL; Grossman NS; Langmore SE
J Am Geriatr Soc; 1995 Apr; 43(4):401-7. PubMed ID: 7706631
[TBL] [Abstract][Full Text] [Related]
3. Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review.
Prado-Mel E; Ciudad-Gutiérrez P; Rodríguez-Ramallo H; Sánchez-Fidalgo S; Santos-Ramos B; Villalba-Moreno AM
BMC Pharmacol Toxicol; 2022 Dec; 23(1):94. PubMed ID: 36539885
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults.
Tiisanoja A; Syrjälä AM; Komulainen K; Lampela P; Hartikainen S; Taipale H; Knuuttila M; Ylöstalo P
Gerodontology; 2018 Mar; 35(1):3-10. PubMed ID: 28940566
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the use of xerogenic medications for chronic medical and dental conditions among adult day health participants.
Lam A; Kiyak A; Gossett AM; McCormick L
Consult Pharm; 2009 Oct; 24(10):755-64. PubMed ID: 20017410
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic Burden and Xerostomia in Critical Care Settings.
Chung J; Tjia J; Zhang N; O'Connor BT
Dimens Crit Care Nurs; 2023 Nov-Dec 01; 42(6):310-318. PubMed ID: 37756502
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
8. The interrelationship between xerogenic medication use, subjective oral dryness and tooth wear.
Alwaheidi HAA; O'Toole S; Bernabé E
J Dent; 2021 Jan; 104():103542. PubMed ID: 33276080
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of medication-induced xerostomia and effect of treatment.
Ito K; Izumi N; Funayama S; Nohno K; Katsura K; Kaneko N; Inoue M
PLoS One; 2023; 18(1):e0280224. PubMed ID: 36634078
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of xerostomia and hyposalivation in the nursing home and the relation with number of prescribed medication].
van der Putten GJ; Brand HS; Bots CP; van Nieuw Amerongen A
Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):30-6. PubMed ID: 12629908
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of xerostomia and its association with systemic diseases and medications in the elderly: a cross-sectional study.
Fornari CB; Bergonci D; Stein CB; Agostini BA; Rigo L
Sao Paulo Med J; 2021; 139(4):380-387. PubMed ID: 34190871
[TBL] [Abstract][Full Text] [Related]
12. Xerostomia and polypharmacy among dependent older New Zealanders: a national survey.
Thomson WM; Ferguson CA; Janssens BE; Kerse NM; Ting GS; Smith MB
Age Ageing; 2021 Jan; 50(1):248-251. PubMed ID: 32706865
[TBL] [Abstract][Full Text] [Related]
13. [Xerostomia and its impact on oral health-related quality of life].
Herrmann G; Müller K; Behr M; Hahnel S
Z Gerontol Geriatr; 2017 Feb; 50(2):145-150. PubMed ID: 26508110
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Nederfors T
Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and saliva volumes in the northeast of Germany - The Study of Health in Pomerania.
Laugisch O; Holtfreter B; Pink C; Samietz S; Völzke H; Kocher T
Community Dent Oral Epidemiol; 2022 Apr; 50(2):139-146. PubMed ID: 33829548
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic burden of medications is associated with dry mouth and reflected in minor labial gland secretion.
Michail A; Almirza M; Alwaely F; Arany S
Arch Oral Biol; 2023 Dec; 156():105824. PubMed ID: 37865013
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and factors associated with xerostomia and hyposalivation among community-dwelling older people in Japan.
Ohara Y; Hirano H; Yoshida H; Obuchi S; Ihara K; Fujiwara Y; Mataki S
Gerodontology; 2016 Mar; 33(1):20-7. PubMed ID: 24304087
[TBL] [Abstract][Full Text] [Related]
18. The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants.
Janket SJ; Jones J; Rich S; Miller D; Wehler CJ; Van Dyke TE; Garcia R; Meurman JH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):223-30. PubMed ID: 17234540
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy.
Nederfors T; Isaksson R; Mörnstad H; Dahlöf C
Community Dent Oral Epidemiol; 1997 Jun; 25(3):211-6. PubMed ID: 9192149
[TBL] [Abstract][Full Text] [Related]
20. Medication and perception of dry mouth in a population of institutionalised elderly people.
Thomson WM; Brown RH; Williams SM
N Z Med J; 1993 Jun; 106(957):219-21. PubMed ID: 8367076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
